Discover the Truth About Weight Loss Injections: Types, Benefits, and What You Must Know!

Losing weight can be a significant challenge, especially when lifestyle adjustments alone aren't enough. Weight loss injections, such as Wegovy and Zepbound, have become increasingly popular as tools to aid in more effective weight management. These treatments regulate appetite, metabolism, and blood sugar levels, often leading to gradual weight loss over time. However, it's essential to understand how these injections work, their potential benefits, and associated risks before considering them.

What are Weight Loss Injections?

Weight loss injections are medications typically administered weekly to help regulate appetite, metabolism, and blood sugar levels. Many of the most effective injections were initially developed to treat type 2 diabetes but are now FDA-approved (or prescribed off-label) for weight loss.

FDA-Approved and Commonly Prescribed Injections

Wegovy (semaglutide): Approved for chronic weight management in adults and teens. In August 2025, Wegovy received accelerated approval for the treatment of adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.
Ozempic (semaglutide): Used off-label for weight loss; originally for diabetes.
Mounjaro (tirzepatide): Dual-acting injection for diabetes and obesity.
Saxenda (liraglutide): Daily injection approved for weight loss.
Zepbound (tirzepatide): Newly approved for chronic weight management. Zepbound (tirzepatide) for chronic weight management (weight reduction and maintenance) was studied in 2 randomized, placebo-controlled, 72-week long, studies (SURMOUNT-1 and SURMOUNT-2) in over 3,400 adults with obesity or excess weight (overweight) and at least one weight-related condition.

These medications often mimic hormones like GLP-1, helping individuals feel fuller for longer periods, eat less, and lose weight gradually.

Other Injections: Lipotropic, HCG, and B12

Some clinics may promote injections like:

Lipotropic injections (fat burners with B12 and amino acids)
HCG injections (used with a very low-calorie diet)
B12 injections (boost energy and metabolism)

However, it's crucial to note that these injections are not FDA-approved for weight loss and lack strong clinical evidence. It's essential to consult with a qualified medical provider before considering these options.

Read also: Weight Loss Guide Andalusia, AL

Benefits of Weight Loss Injections

For suitable candidates, weight loss injections can provide several benefits, especially when combined with a healthy diet and regular physical activity.

Faster Weight Loss: Injections can accelerate the weight loss process when combined with diet and exercise.
Appetite Control: These injections can help curb cravings and manage portion sizes, making it easier to adhere to a reduced-calorie diet.
Improved Metabolism: Weight loss injections can support the body in burning calories more efficiently, potentially leading to increased weight loss.
Better Blood Sugar Control: This is particularly important for individuals with insulin resistance or type 2 diabetes, as some injections were initially developed for diabetes treatment.

Potential Risks and Side Effects

Like all medications, weight loss injections carry potential risks and side effects. The most common side effects include:

Nausea
Vomiting
Diarrhea or constipation
Headaches
Allergic reactions (rare)

Weight loss injections are not suitable for everyone, especially those with a history of certain thyroid issues, pancreatitis, or other chronic conditions. Consulting with a specialist is essential to determine if these injections are right for you.

Determining Candidacy for Weight Loss Injections

Weight loss injections are generally recommended for adults with:

A BMI of 30 or greater
A BMI of 27 or greater with a related health condition like diabetes, PCOS, or high blood pressure

Doctors may also suggest injections for individuals who have tried other weight loss methods without success and need additional support.

Specific Weight Loss Injections: A Closer Look

Semaglutide (Wegovy, Ozempic)

Semaglutide, marketed as Wegovy for weight loss and Ozempic for diabetes, is a GLP-1 receptor agonist. Semaglutide binds to GLP-1 receptors and stimulates insulin release from the pancreas when needed. It helps with weight loss by slowing down how fast food travels through your digestive tract (called gastric emptying). This may help you to feel fuller for a longer period and reduce how much food you consume.

Dosage: Wegovy single-dose pens are available in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg doses. Treatment typically starts with 0.25 mg subcutaneously once weekly for four weeks, gradually increasing the dose in four-week intervals until a maintenance dose of 1.7 mg or 2.4 mg is reached. Ozempic injection pens deliver 0.25 mg, 0.5 mg, 1 mg, and 2 mg doses. The initial dose is 0.25 mg given subcutaneously once weekly (but is not used as an ongoing maintenance dose). After 4 weeks, the dose is increased to 0.5 mg once weekly. The maximum recommended dose of Ozempic for blood sugar control is 2 mg weekly.
Efficacy: In clinical trials, Wegovy has demonstrated an average weight loss of around 15% of body weight, while Ozempic has shown a weight loss of 6% to 7%. In STEP 1, the average starting weight for both groups was about 105 kg (232 lb). Over the 68-week period, adults in the group taking Wegovy lost significantly more weight than those taking an inactive placebo. With Wegovy, an average of 15.9 kg (35 lb), or about 15% of body weight, was seen. In addition, about 84% of people taking Wegovy lost 5% or more of their weight (vs. 31% of people on placebo); 66% lost 10% or more (vs. 12% on placebo), and 48% lost 15% or more (vs. 5% on placebo). Also, 77% of patients in the Wegovy group had a BMI reduction of at least 5% vs.
Cardiovascular Benefits: Ozempic and Wegovy are both approved for cardiovascular risk reduction, meaning they can reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and type 2 diabetes mellitus (Ozempic) or obesity or overweight (Wegovy).
Side Effects: Common side effects include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion (dyspepsia), and stomach (abdominal) pain.

Tirzepatide (Mounjaro, Zepbound)

Tirzepatide, available as Mounjaro for diabetes and Zepbound for weight loss, is a dual-acting GIP and GLP-1 receptor agonist. GIP and GLP-1 are both natural incretin hormones. Mounjaro lowers fasting and postprandial (after meals) glucose concentration, decreases food intake, and reduces body weight in patients with type 2 diabetes mellitus.

Dosage: Mounjaro (tirzepatide) injection single-use pens or vials are available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5, and 15 mg doses. The recommended starting dosage is 2.5 mg subcutaneously once weekly, increasing to 5 mg once weekly after 4 weeks. If additional blood sugar control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose. Zepbound (tirzepatide) single-use pens deliver 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5, and 15 mg doses. The recommended starting dosage is 2.5 mg subcutaneously once weekly, increasing to 5 mg once weekly after 4 weeks. The recommended maintenance dosages are 5 mg, 10 mg, or 15 mg injected subcutaneously once weekly.
Efficacy: Studies have shown significant weight loss with tirzepatide. In studies for patients using Zepbound (tirzepatide), a 21% weight-loss (up to 52 lb) using the highest dose (15 mg) was demonstrated in patients without type 2 diabetes. In Phase 3 studies in patients with type 2 diabetes, those treated with Mounjaro lost an average of 5.5 kg (12 lb) to 11 kg (25 lb) over 52-weeks.
Side Effects: The most common side effects are mild-to-moderate nausea, diarrhea, and constipation, primarily during the dose escalation period.

Liraglutide (Saxenda, Victoza)

Liraglutide, marketed as Saxenda for weight loss and Victoza for diabetes, is a daily injectable medication that acts on hormones that send signals from the gut to the brain to make the patient feel full quicker and decrease hunger signals.

Dosage: Doses start at 0.6 mg to 3 mg a day.
Efficacy: Some patients may lose 5â10% of body weight, especially with the higher dose of liraglutide.
Side Effects: Side effects include nausea, diarrhea, constipation, vomiting, headache, decreased appetite, dyspepsia, fatigue, dizziness, abdominal pain, increased lipase, and renal insufficiency.

Important Safety Information for GLP-1 Receptor Agonists and Dual Agonists

Thyroid Tumors: The labeling of these medicines carries a Boxed Warning for possible thyroid tumors, including cancer, which has been seen in animal studies. Do not use Ozempic, Mounjaro, Wegovy, or Zepbound if you or anyone in your family has a history of medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Gastrointestinal Side Effects: Gastrointestinal (digestive tract) side effects are the most common side effects reported in at least 5% of patients with these medications. Nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion (dyspepsia), and stomach (abdominal) pain have been reported.
Intestinal Obstruction: After these medicines were approved by the FDA, ileus was reported as a possible side effect and updated in the product labels. An ileus (paralytic ileus) is an intestinal blockage that results in the failure of the intestinal contents to pass through the gut, but it doesn't involve a physical blockage.
Anesthesia Considerations: There have also been concerns about the use of incretin mimetics (GLP-1 type medications) in patients undergoing general anesthesia. These medications can lead to a delay in stomach (gastric) emptying. The American Society of Anesthesiologists suggests that adults and children on these types of GLP-1 medicines stop taking it prior to surgery.

Additional Weight Loss Medications

Besides GLP-1 receptor agonists and dual agonists, other weight loss medications are available, each with its mechanisms of action, dosages, and side effects.

Phentermine: The oldest and most widely used weight loss medication. Side effects include headache, overstimulation, high blood pressure, insomnia, rapid or irregular heart rate, and tremor.
Phentermine-Topiramate (Qsymia): Topiramate can be combined with phentermine to decrease appetite and cravings. Side effects include abnormal sensations, dizziness, altered taste, insomnia, constipation, and dry mouth.
Naltrexone-Bupropion (Contrave): Combines an opioid receptor antagonist with an antidepressant to affect the pleasure-reward areas of the brain and thereby decrease cravings and appetite. The most common side effects include nausea, constipation, headache, vomiting, dizziness, insomnia, dry mouth, and diarrhea.
Orlistat (Xenical, Alli): A lipase inhibitor that comes in a capsule. Undigested fat is then passed through the body. Side effects include oily stool, fecal urgency, and flatulence.
Setmelanotide: A melanocortin-4 receptor agonist indicated for chronic weight management in adult and pediatric patients six years and older, with obesity due to certain rare genetic disorders.

The Future of Weight Loss Medications

The field of weight loss medications is rapidly evolving, with several new options on the horizon.

Read also: Inspiring Health Transformation

Orforglipron (Eli Lilly): An oral GLP-1 inhibitor that completed a Phase 3 clinical trial in early 2025.
Retatrutide (Eli Lilly): Targets GLP-1, GIP, and glucagon. It is currently in Phase 3 clinical trials.
MariTide (Amgen): A monoclonal antibody designed to increase GLP-1 receptor activity while reducing GIP receptor activity. The once-monthly injection entered Phase 3 clinical trials in March 2025.

Researchers continue to study hormones that play a role in appetite for other ways to target obesity with medication.

Important Considerations

Lifestyle Changes: Weight loss medications are most effective when combined with a healthy eating plan and exercise.
Insurance Coverage: Insurance coverage for weight loss medications varies and can significantly impact a patient's decision to pursue this treatment option.
Compounded Medications: The FDA warns against buying medications from any source other than a state-licensed pharmacy. Compounded versions of medications are not FDA-approved.
Long-Term Use: Some weight management medications are designed for short-term use, while others are approved for long-term use.
Weight Regain: Most people regain weight if AOMs are discontinued.

tags: #weight #loss #injections #types #and #effectiveness